SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015969
Filing Date
2021-11-15
Accepted
2021-11-15 16:06:52
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210930x10q.htm   iXBRL 10-Q 1048236
2 EX-10.2 tmb-20210930xex10d2.htm EX-10.2 25828
3 EX-31.1 tmb-20210930xex31d1.htm EX-31.1 14534
4 EX-31.2 tmb-20210930xex31d2.htm EX-31.2 14557
5 EX-32.1 tmb-20210930xex32d1.htm EX-32.1 7210
6 EX-32.2 tmb-20210930xex32d2.htm EX-32.2 7179
  Complete submission text file 0001558370-21-015969.txt   4537059

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20210930.xsd EX-101.SCH 42564
8 EX-101.CAL tmb-20210930_cal.xml EX-101.CAL 33889
9 EX-101.DEF tmb-20210930_def.xml EX-101.DEF 142817
10 EX-101.LAB tmb-20210930_lab.xml EX-101.LAB 393437
11 EX-101.PRE tmb-20210930_pre.xml EX-101.PRE 275900
12 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210930x10q_htm.xml XML 565796
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 211410431
SIC: 2834 Pharmaceutical Preparations